Arthur W. Nienhuis - Concepedia

Author

Arthur W. Nienhuis

Also Known As

A Nienhuis, A W Nienhuis, A. NIENHUIS, A. Nienhuis, A. W. Nienhuis, A.W. Nienhuis, ARTHUR NIENHUIS, ARTHUR W. NIENHUIS, AW Nienhuis, Arthur Nienhuis

319

Publications

23K

Citations

H-Index

209

Concepts

All Affiliations

National Heart Lung and Blood Institute St. Jude Children's Research Hospital National Institutes of Health Lung Institute National Cancer Institute

About

Arthur W. Nienhuis is an author at National Heart Lung and Blood Institute specializing in medicine, cell biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	58	120	10.6K
2	Health Sciences	22	27	2.3K
3	Natural Sciences	20	25	1.9K
4	Engineering	5	5	579
5	Education	1	1	18

Arthur W. Nienhuis

191

Publications

21K

Citations

H-Index

Page 1

	Year	Citations
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, New England Journal of Medicine	2011	1.8K
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham, New England Journal of Medicine	2014	1.2K
Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major Gary M. Brittenham, Patricia Griffith, Arthur W. Nienhuis, New England Journal of Medicine	1994	844
Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human <i>MDR</i> 1 Brian P. Sorrentino, Stephen J. Brandt, David M. Bodine, Science	1992	493
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β<sup>+</sup>Thalassemia Timothy J. Ley, Joseph DeSimone, Nicholas P. Anagnou, New England Journal of Medicine 5-Azacytidine SelectivityBone Marrow FailureBiochemistryMedicineBone-marrow Dna	1982	493
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. J T Holt, Robert L. Redner, Arthur W. Nienhuis Molecular and Cellular Biology Complementary OligomerMolecular RegulationImmunologyCell ProliferationCellular Physiology	1988	473
Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin Therapy Gary J. Kurtzman, Norbert Frickhofen, Janice Kimball, New England Journal of Medicine VaccinationViral PersistenceBone Marrow FailureDuration DuePathogenesis	1989	433
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins Amit C. Nathwani, Cecilia Rosales, Jenny McIntosh, Molecular Therapy	2011	343
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. Stephen J. Brandt, David M. Bodine, Cynthia E. Dunbar, Journal of Clinical Investigation ImmunologyImmune RegulationPathologyImmune SystemImmunotherapy	1990	334
Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload Richard D. Propper, Barry Cooper, R Rufo, New England Journal of Medicine Deferoxamine BUrologyContinuous Subcutaneous AdministrationIron MetabolismHematology	1977	333

Page 1